Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Immunotherapy of leukemia

E M Hersh, J U Gutterman, G M Mavligit

    The Medical Clinics of North America
    |September 1, 1976
    PubMed
    Summary

    Immunotherapy shows promise in extending remission and survival for leukemia patients. Further research is needed for acute lymphocytic leukemias and chronic lymphocytic leukemia, but potential is high for lymphomas.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    A randomized, controlled phase III trial of nab-Paclitaxel versus dacarbazine in chemotherapy-naïve patients with metastatic melanoma.

    Annals of oncology : official journal of the European Society for Medical Oncology·2015
    Same author

    Transduction of human dendritic cells with a recombinant modified vaccinia Ankara virus encoding MUC1 and IL-2.

    Cancer immunology, immunotherapy : CII·2001
    Same author

    Cationic lipid-mediated gene transfer: current concepts.

    Current opinion in molecular therapeutics·2001
    Same author

    Phase II study of direct intralesional gene transfer of allovectin-7, an HLA-B7/beta2-microglobulin DNA-liposome complex, in patients with metastatic melanoma.

    Clinical cancer research : an official journal of the American Association for Cancer Research·2001
    Same author

    Preclinical antitumor activity of the azonafide series of anthracene-based DNA intercalators.

    Anti-cancer drugs·2001
    Same author

    A phase I and pharmacodynamic evaluation of polyethylene glycol-conjugated L-asparaginase in patients with advanced solid tumors.

    Cancer chemotherapy and pharmacology·2001

    Area of Science:

    • Oncology
    • Immunology

    Background:

    • Immunotherapy is a treatment modality that harnesses the immune system to fight cancer.
    • Leukemia and malignant lymphomas are cancers of blood cells and lymph nodes, respectively.
    • Immunodeficiency is often observed in patients with these hematological malignancies.

    Purpose of the Study:

    • To review the effectiveness of immunotherapy in prolonging remission and survival in leukemia and malignant lymphomas.
    • To identify areas for future research in the immunotherapy of hematological malignancies.

    Main Methods:

    • Review of existing data and studies on immunotherapy for leukemia and lymphomas.
    • Analysis of the scientific basis for immunotherapy, including tumor-associated antigens and immune responses.

    Main Results:

    • Immunotherapy is effective in prolonging remission and survival in acute and chronic leukemia.
    • Acute lymphocytic leukemias show variable response to immunotherapy, requiring further investigation.
    • Malignant lymphomas present a promising area for immunotherapy research due to high response rates and identifiable antigens.
    • Active nonspecific immunotherapy (BCG, MER) and active specific immunotherapy are effective in acute myelogenous leukemia.

    Conclusions:

    • Immunotherapy offers a viable strategy for improving outcomes in leukemia and lymphoma patients.
    • Further research is crucial for optimizing immunotherapy protocols and exploring novel approaches, particularly for specific leukemia subtypes and lymphomas.

    Related Experiment Videos